Short Interest in Guardion Health Sciences, Inc. (NASDAQ:GHSI) Increases By 48.4%

Guardion Health Sciences, Inc. (NASDAQ:GHSIGet Rating) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 6,560,000 shares, an increase of 48.4% from the March 31st total of 4,420,000 shares. Based on an average daily trading volume, of 7,570,000 shares, the short-interest ratio is currently 0.9 days.

Several institutional investors have recently added to or reduced their stakes in the company. Virtu Financial LLC bought a new position in shares of Guardion Health Sciences during the 4th quarter valued at approximately $40,000. Two Sigma Advisers LP bought a new position in Guardion Health Sciences in the 3rd quarter worth approximately $31,000. Millennium Management LLC bought a new position in Guardion Health Sciences in the 3rd quarter worth approximately $106,000. Renaissance Technologies LLC boosted its holdings in Guardion Health Sciences by 68.4% in the 3rd quarter. Renaissance Technologies LLC now owns 584,792 shares of the company’s stock worth $743,000 after buying an additional 237,501 shares during the period. Finally, Morgan Stanley boosted its holdings in Guardion Health Sciences by 2,326.1% in the 2nd quarter. Morgan Stanley now owns 326,987 shares of the company’s stock worth $575,000 after buying an additional 313,509 shares during the period. 12.32% of the stock is owned by hedge funds and other institutional investors.

Separately, Maxim Group initiated coverage on shares of Guardion Health Sciences in a research report on Tuesday, March 8th. They set a “buy” rating and a $0.60 target price for the company.

Shares of Guardion Health Sciences stock traded down $0.01 on Friday, reaching $0.19. 1,466,242 shares of the company traded hands, compared to its average volume of 5,446,723. Guardion Health Sciences has a 52 week low of $0.16 and a 52 week high of $2.18. The company has a 50 day moving average of $0.22 and a 200 day moving average of $0.64.

Guardion Health Sciences Company Profile (Get Rating)

Guardion Health Sciences, Inc, together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.

Featured Stories

Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.